Cardiovascular disease, single nucleotide polymorphisms; And the renin angiotensin system: Is there a microrna connection?

International Journal of Hypertension

Volumn 2010, Issue , 2010, Pages

  Elton, Terry S ^a,b,c   Sansom, Sarah E ^a   Martin, Mickey M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; MICRORNA;

3' UNTRANSLATED REGION; ALGORITHM; AT1R GENE; BINDING SITE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE INTERACTION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEART FUNCTION; HORMONE ACTION; HORMONE METABOLISM; HORMONE SYNTHESIS; HUMAN; HYPERTENSION; MOLECULAR BIOLOGY; PATHOGENESIS; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN DISORDER; REVIEW; RNA BINDING; RNA PROCESSING; RNA SYNTHESIS; SINGLE NUCLEOTIDE POLYMORPHISM; VALIDATION PROCESS;

EID: 80053298030     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2010/281692     Document Type: Review

References (129)

1. Kruglyak L., Nickerson D. A., Variation is the spice of life. Nature Genetics 2001 27 3 234 236 2-s2.0-0035094764 10.1038/85776 (Pubitemid 32201838)
2. Sherry S. T., Ward M., Sirotkin K., dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Research 1999 9 8 677 679 2-s2.0-0032876978 (Pubitemid 29412785)
3. Venter J. C., Adams M. D., Myers E. W., Li P. W., Mural R. J., Sutton G. G., Smith H. O., Yandell M., Evans C. A., Holt R. A., Gocayne J. D., Amanatides P., Ballew R. M., Huson D. H., Wortman J. R., Zhang Q., Kodira C. D., Zheng X. H., Chen L., Skupski M., Subramanian G., Thomas P. D., Zhang J., Gabor Miklos G. L., Nelson C., Broder S., Clark A. G., Nadeau J., McKusick V. A., Zinder N., Levine A. J., Roberts R. J., Simon M., Slayman C., Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M., Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C., Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K., Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R., Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K., Evangelista C., Gabrielian A. E., Gan W., Ge W., Gong F., Gu Z., Guan P., Heiman T. J., Higgins M. E., Ji R.-R., Ke Z., Ketchum K. A., Lai Z., Lei Y., Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G. V., Milshina N., Moore H. M., Naik A. K., Narayan V. A., Neelam B., Nusskern D., Rusch D. B., Salzberg S., Shao W., Shue B., Sun J., Z. Y. W., Wang A., Wang X., Wang J., Wei M.-H., Wides R., Xiao C., The sequence of the human genome. Science 2001 291 5507 1304 1351 2-s2.0-0035895505 10.1126/science.1058040 (Pubitemid 32173090)
4. Nückel H., Frey U. H., Bau M., Sellmann L., Stanelle J., Dürig J., Jöckel K.-H., Dührsen U., Siffert W., Association of a novel regulatory polymorphism (-938 C>A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia. Blood 2007 109 1 290 297 2-s2.0-33846004731 10.1182/blood-2006-03-007567 (Pubitemid 46053069)
5. Krawczak M., Reiss J., Cooper D. N., The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Human Genetics 1992 90 1-2 41 54 2-s2.0-0026794668
6. Bartel D. P., MicroRNAs: target Recognition and Regulatory Functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
7. De Gasparo M., Catt K. J., Inagami T., Wright J. W., Unger TH., International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacological Reviews 2000 52 3 415 472 2-s2.0-0033824138
8. Thomas W. G., Mendelsohn F. A. O., Angiotensin receptors: form and function and distribution. International Journal of Biochemistry and Cell Biology 2003 35 6 774 779 2-s2.0-0037409311 10.1016/S1357-2725(02)00263-7 (Pubitemid 36379318)
9. Hunyady L., Catt K. J., Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Molecular Endocrinology 2006 20 5 953 970 2-s2.0-29344452247 10.1210/me.2004-0536
10. Mehta P. K., Griendling K. K., Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. American Journal of Physiology 2007 292 1 C82 C97 2-s2.0-33846362954 10.1152/ajpcell. 00287.2006 (Pubitemid 46127306)
11. Elton T. S., Martin M. M., Angiotensin II type 1 receptor gene regulation: transcriptional and posttranscriptional mechanisms. Hypertension 2007 49 5 953 961 2-s2.0-34247868824 10.1161/HYPERTENSIONAHA.106.070565 (Pubitemid 351664299)
12. Oro C., Qian H., Thomas W. G., Type 1 angiotensin receptor pharmacology: signaling beyond G proteins. Pharmacology and Therapeutics 2007 113 1 210 226 2-s2.0-33845693028 10.1016/j.pharmthera.2006.10.001 (Pubitemid 44969930)
13. Porrello E. R., Delbridge L. M., Thomas W. G., The angiotensin II type 2 (AT2) receptor: an enigmatic seven transmembrane receptor. Frontiers in Bioscience 2009 14 958 972 2-s2.0-63849169364
14. Jones E. S., Vinh A., McCarthy C. A., Gaspari T. A., Widdop R. E., AT2 receptors: functional relevance in cardiovascular disease. Pharmacology and Therapeutics 2008 120 3 292 316 2-s2.0-56149096807 10.1016/j.pharmthera.2008.08. 009
15. Crackower M. A., Sarao R., Oudit G. Y., Yagil C., Kozieradzki I., Scanga S. E., Oliveira-dos-Santos A. J., Da Costa J., Zhang L., Pei Y., Scholey J., Ferrarlo C. M., Manoukian A. S., Chappell M. C., Backx P. H., Yagil Y., Penninger J. M., Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002 417 6891 822 828 2-s2.0-0037142101 10.1038/nature00786 (Pubitemid 34670323)
16. Chappell M. C., Gregory Modralt J., Diz D. I., Ferrario C. M., Novel aspects of the renal renin-angiotensin system: angiotensin-(1-7),ACE2 and blood pressure regulation. Contributions to Nephrology 2004 143 77 89 2-s2.0-3242695312
17. Raizada M. K., Ferreira A. J., ACE2: a new target for cardiovascular disease therapeutics. Journal of Cardiovascular Pharmacology 2007 50 2 112 119 2-s2.0-34547951695 10.1097/FJC.0b013e3180986219 (Pubitemid 47267736)
18. Iwai M., Horiuchi M., Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis. Hypertension Research 2009 32 7 533 536 2-s2.0-67650541842 10.1038/hr.2009.74
19. Danser A. H. J., Local renin-angiotensin systems. Molecular and Cellular Biochemistry 1996 157 1-2 211 216 2-s2.0-0029880304 (Pubitemid 26142454)
20. Petrie M. C., Padmanabhan N., McDonald J. E., Hillier C., Connell J. M. C., McMurray J. J. V., Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. Journal of the American College of Cardiology 2001 37 4 1056 1061 2-s2.0-0035869572 10.1016/S0735-1097(01)01111-1 (Pubitemid 32217606)
21. Timmermans P. B. M. W. M., Wong P. C., Chiu A. T., Herblin W. F., Nonpeptide angiotensin II receptor antagonists. Trends in Pharmacological Sciences 1991 12 2 55 62 2-s2.0-0026078602 10.1016/0165-6147(91)90498-H
22. Timmermans P. B. M. W. M., Wong P. C., Chiu A. T., Herblin W. F., Benfield P., Carini D. J., Lee R. J., Wexler R. R., Saye J. A. M., Smith R. D., Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacological Reviews 1993 45 2 205 251 2-s2.0-0027208070 (Pubitemid 23191415)
23. Chai S. Y., Fernando R., Peck G., Ye S.-Y., Mendelsohn F. A. O., Jenkins T. A., Albiston A. L., The angiotensin IV/AT4 receptor. Cellular and Molecular Life Sciences 2004 61 21 2728 2737 2-s2.0-11144314693 10.1007/s00018-004-4246-1 (Pubitemid 40022434)
24. Vanderheyden P. M. L., From angiotensin IV binding site to AT4 receptor. Molecular and Cellular Endocrinology 2009 302 2 159 166 2-s2.0-62949248271 10.1016/j.mce.2008.11.015
25. Danser A. H. J., (Pro)renin receptors: are they biologically relevant? Current Opinion in Nephrology and Hypertension 2009 18 1 74 78 2-s2.0-58149216360 10.1097/MNH.0b013e3283196aaf
26. Nguyen G., Muller D. N., The biology of the (pro)renin receptor. Journal of the American Society of Nephrology 2010 21 1 18 23 2-s2.0-67049144916 10.1681/ASN.2009030300
27. Danser A. H. J., The increase in renin during renin inhibition: does it result in harmful effects by the (pro)renin receptor. Hypertension Research 2010 33 1 4 10 2-s2.0-47049093197 10.1038/hr.2009.186
28. Bushati N., Cohen S. M., MicroRNA functions. Annual Review of Cell and Developmental Biology 2007 23 175 205 2-s2.0-34547960488 10.1146/annurev. cellbio.23.090506.123406
29. Brennecke J., Stark A., Russell R. B., Cohen S. M., Principles of microRNA-target recognition. PLoS Biology 2005 3 3, article e85 2-s2.0-24644482193
30. Kiriakidou M., Tan G. S., Lamprinaki S., De Planell-Saguer M., Nelson P. T., Mourelatos Z., An mRNA m7G cap binding-like motif within human Ago2 represses translation. Cell 2007 129 6 1141 1151 2-s2.0-34250017082 10.1016/j.cell.2007.05.016 (Pubitemid 46891041)
31. Humphreys D. T., Westman B. J., Martin D. I. K., Preiss T., MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 16961 16966 2-s2.0-28044457883 10.1073/pnas.0506482102 (Pubitemid 41692666)
32. Bagga S., Bracht J., Hunter S., Massirer K., Holtz J., Eachus R., Pasquinelli A. E., Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 2005 122 4 553 563 2-s2.0-23944514849 10.1016/j.cell.2005.07. 031 (Pubitemid 41191154)
33. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
34. Dalmay T., MicroRNAs and cancer. Journal of Internal Medicine 2008 263 4 366 375 2-s2.0-40349100260 10.1111/j.1365-2796.2008.01926.x (Pubitemid 351342684)
35. Lukiw W. J., Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus. NeuroReport 2007 18 3 297 300 2-s2.0-33847203593 10.1097/WNR.0b013e3280148e8b
36. van Rooij E., Sutherland L. B., Liu N., Williams A. H., McAnally J., Gerard R. D., Richardson J. A., Olson E. N., A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 2006 103 48 18255 18260 2-s2.0-33845317603 10.1073/pnas.0608791103 (Pubitemid 44871645)
37. Berezikov E., Guryev V., van de Belt J., Wienholds E., Plasterk R. H. A., Cuppen E., Phylogenetic shadowing and computational identification of human microRNA genes. Cell 2005 120 1 21 24 2-s2.0-11844262661 10.1016/j.cell.2004.12. 031 (Pubitemid 40094599)
38. Rigoutsos I., Huynh T., Miranda K., Tsirigos A., McHardy A., Platt D., Short blocks from the noncoding parts of the human genome have instances within nearly all known genes and relate to biological processes. Proceedings of the National Academy of Sciences of the United States of America 2006 103 17 6605 6610 2-s2.0-33646242293 10.1073/pnas.0601688103
39. Krek A., Grün D., Poy M. N., Wolf R., Rosenberg L., Epstein E. J., MacMenamin P., Da Piedade I., Gunsalus K. C., Stoffel M., Rajewsky N., Combinatorial microRNA target predictions. Nature Genetics 2005 37 5 495 500 2-s2.0-20944450160 10.1038/ng1536 (Pubitemid 40617277)
40. Hon L. S., Zhang Z., The roles of binding site arrangement and combinatorial targeting in microRNA repression of gene expression. Genome Biology 2007 8 8, article R166 2-s2.0-37349050790 10.1186/gb-2007-8-8-r166 (Pubitemid 351891471)
41. Place R. F., Li L.-C., Pookot D., Noonan E. J., Dahiya R., MicroRNA-373 induces expression of genes with complementary promoter sequences. Proceedings of the National Academy of Sciences of the United States of America 2008 105 5 1608 1613 2-s2.0-40349094597 10.1073/pnas.0707594105 (Pubitemid 351346562)
42. Kim D. H., Sætrom P., Snove O. Jr., Rossi J. J., MicroRNA-directed transcriptional gene silencing in mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 2008 105 42 16230 16235 2-s2.0-55849135596 10.1073/pnas.0808830105
43. Lee Y., Kim M., Han J., Yeom K.-H., Lee S., Baek S. H., Kim V. N., MicroRNA genes are transcribed by RNA polymerase II. EMBO Journal 2004 23 20 4051 4060 2-s2.0-8144225486 10.1038/sj.emboj.7600385 (Pubitemid 39472426)
44. Cai X., Hagedorn C. H., Cullen B. R., Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs. RNA 2004 10 12 1957 1966 2-s2.0-9344235449 10.1261/rna.7135204 (Pubitemid 39557833)
45. Filipowicz W., Bhattacharyya S. N., Sonenberg N., Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 2008 9 2 102 114 2-s2.0-38349169664 10.1038/nrg2290
46. Altuvia Y., Landgraf P., Lithwick G., Elefant N., Pfeffer S., Aravin A., Brownstein M. J., Tuschl T., Margalit H., Clustering and conservation patterns of human microRNAs. Nucleic Acids Research 2005 33 8 2697 2706 2-s2.0-18744367544 10.1093/nar/gki567 (Pubitemid 41511287)
47. Rodriguez A., Griffiths-Jones S., Ashurst J. L., Bradley A., Identification of mammalian microRNA host genes and transcription units. Genome Research 2004 14 10 1902 1910 2-s2.0-6344281172 10.1101/gr.2722704 (Pubitemid 39386503)
48. Kim Y.-K., Kim V. N., Processing of intronic microRNAs. EMBO Journal 2007 26 3 775 783 2-s2.0-33846945735 10.1038/sj.emboj.7601512
49. Song G., Wang L., MiR-433 and miR-127 arise from independent overlapping primary transcripts encoded by the miR-433-127 locus. PLoS ONE 2008 3 10 2-s2.0-55849085033 10.1371/journal.pone.0003574 e3574
50. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V. N., The nuclear RNase III Drosha initiates microRNA processing. Nature 2003 425 6956 415 419 2-s2.0-0141843656 10.1038/nature01957 (Pubitemid 37187272)
51. Du T., Zamore P. D., MicroPrimer: the biogenesis and function of microRNA. Development 2005 132 21 4645 4652 2-s2.0-28044455435 10.1242/dev.02070 (Pubitemid 41685275)
52. Schwarz D. S., Hutvágner G., Du T., Xu Z., Aronin N., Zamore P. D., Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003 115 2 199 208 2-s2.0-10744225153 10.1016/S0092-8674(03)00759-1 (Pubitemid 37329583)
53. Khvorova A., Reynolds A., Jayasena S. D., Functional siRNAs and miRNAs exhibit strand bias. Cell 2003 115 2 209 216 2-s2.0-0142165224 10.1016/S0092-8674(03)00801-8 (Pubitemid 37329584)
54. Peters L., Meister G., Argonaute Proteins: mediators of RNA Silencing. Molecular Cell 2007 26 5 611 623 2-s2.0-34249810892 10.1016/j.molcel.2007.05.001 (Pubitemid 46856239)
55. Tolia N. H., Joshua-Tor L., Slicer and the argonautes. Nature Chemical Biology 2007 3 1 36 43 2-s2.0-33845774243 10.1038/nchembio848 (Pubitemid 46005696)
56. Rana T. M., Illuminating the silence: understanding the structure and function of small RNAs. Nature Reviews Molecular Cell Biology 2007 8 1 23 36 2-s2.0-33845755467 10.1038/nrm2085 (Pubitemid 46012012)
57. Doench J. G., Sharp P. A., Specificity of microRNA target selection in translational repression. Genes and Development 2004 18 5 504 511 2-s2.0-1642374097 10.1101/gad.1184404 (Pubitemid 38372808)
58. Lewis B. P., Burge C. B., Bartel D. P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005 120 1 15 20 2-s2.0-11844278458 10.1016/j.cell.2004.12.035 (Pubitemid 40094598)
59. Grimson A., Farh K. K.-H., Johnston W. K., Garrett-Engele P., Lim L. P., Bartel D. P., MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Molecular Cell 2007 27 1 91 105 2-s2.0-34250805982 10.1016/j.molcel.2007.06.017 (Pubitemid 46991392)
60. Nielsen C. B., Shomron N., Sandberg R., Hornstein E., Kitzman J., Burge C. B., Determinants of targeting by endogenous and exogenous microRNAs and siRNAs. RNA 2007 13 11 1894 1910 2-s2.0-35548996307 10.1261/rna.768207 (Pubitemid 350005216)
61. Bartel D. P., MicroRNAs: target recognition and regulatory functions. Cell 2009 136 2 215 233 2-s2.0-58249088751 10.1016/j.cell.2009.01.002
62. Wu L., Fan J., Belasco J. G., MicroRNAs direct rapid deadenylation of mRNA. Proceedings of the National Academy of Sciences of the United States of America 2006 103 11 4034 4039 2-s2.0-33645119514 10.1073/pnas.0510928103
63. Behm-Ansmant I., Rehwinkel J., Doerks T., Stark A., Bork P., Izaurralde E., mRNA degradation by miRNAs and GW182 requires both CCR4:NOT deadenylase and DCP1:DCP2 decapping complexes. Genes and Development 2006 20 14 1885 1898 2-s2.0-33746055678 10.1101/gad.1424106 (Pubitemid 44079326)
64. Eulalio A., Rehwinkel J., Stricker M., Huntzinger E., Yang S.-F., Doerks T., Dorner S., Bork P., Boutros M., Izaurralde E., Target-specific requirements for enhancers of decapping in miRNA-mediated gene silencing. Genes and Development 2007 21 20 2558 2570 2-s2.0-35348962568 10.1101/gad.443107 (Pubitemid 47607667)
65. Giraldez A. J., Mishima Y., Rihel J., Grocock R. J., Van Dongen S., Inoue K., Enright A. J., Schier A. F., Zebrafish MiR-430 promotes deadenylation and clearance of maternal mRNAs. Science 2006 312 5770 75 79 2-s2.0-33645124258 10.1126/science.1122689
66. Humphreys D. T., Westman B. J., Martin D. I. K., Preiss T., MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proceedings of the National Academy of Sciences of the United States of America 2005 102 47 16961 16966 2-s2.0-28044457883 10.1073/pnas.0506482102 (Pubitemid 41692666)
67. Pillai R. S., Bhattacharyya S. N., Artus C. G., Zoller T., Cougot N., Basyuk E., Bertrand E., Filipowicz W., Molecular biology: inhibition of translational initiation by let-7 microRNA in human cells. Science 2005 309 5740 1573 1576 2-s2.0-24644480213 10.1126/science.1115079 (Pubitemid 41266485)
68. Thermann R., Hentze M. W., Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation. Nature 2007 447 7146 875 878 2-s2.0-34249282243 10.1038/nature05878 (Pubitemid 46920140)
69. Mathonnet G., Fabian M. R., Svitkin Y. V., Parsyan A., Huck L., Murata T., Biffo S., Merrick W. C., Darzynkiewicz E., Pillai R. S., Filipowicz W., Duchaine T. F., Sonenberg N., MicroRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F. Science 2007 317 5845 1764 1767 2-s2.0-34547944309 10.1126/science.1146067 (Pubitemid 47461843)
70. Wakiyama M., Takimoto K., Ohara O., Yokoyama S., Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system. Genes & Development 2007 21 15 1857 1862 2-s2.0-34547623022 10.1101/gad.1566707 (Pubitemid 47204925)
71. Chendrimada T. P., Finn K. J., Ji X., Baillat D., Gregory R. I., Liebhaber S. A., Pasquinelli A. E., Shiekhattar R., MicroRNA silencing through RISC recruitment of eIF6. Nature 2007 447 7146 823 828 2-s2.0-34249282938 10.1038/nature05841 (Pubitemid 46920131)
72. Alexiou P., Maragkakis M., Papadopoulos G. L., Reczko M., Hatzigeorgiou A. G., Lost in translation: an assessment and perspective for computational microrna target identification. Bioinformatics 2009 25 23 3049 3055 2-s2.0-34447521718 10.1093/bioinformatics/btp565
73. Maragkakis M., Alexiou P., Papadopoulos G. L., Reczko M., Dalamagas T., Giannopoulos G., Goumas G., Koukis E., Kourtis K., Simossis V. A., Sethupathy P., Vergoulis T., Koziris N., Sellis T., Tsanakas P., Hatzigeorgiou A. G., Accurate microRNA target prediction correlates with protein repression levels. BMC Bioinformatics 2009 10, article 1471 295 2-s2.0-70449372292 10.1186/1471-2105-10-295
74. Friedman R. C., Farh K. K.-H., Burge C. B., Bartel D. P., Most mammalian mRNAs are conserved targets of microRNAs. Genome Research 2009 19 1 92 105 2-s2.0-60149095444 10.1101/gr.082701.108
75. Lall S., Grün D., Krek A., Chen K., Wang Y.-L., Dewey C. N., Sood P., Colombo T., Bray N., MacMenamin P., Kao H.-L., Gunsalus K. C., Pachter L., Piano F., Rajewsky N., A genome-wide map of conserved microRNA targets in C. elegans. Current Biology 2006 16 5 460 471 2-s2.0-33644756532 10.1016/j.cub.2006.01.050 (Pubitemid 43343706)
76. Gaidatzis D., van Nimwegen E., Hausser J., Zavolan M., Inference of miRNA targets using evolutionary conservation and pathway analysis. BMC Bioinformatics 2007 8 1 69 2-s2.0-34347398567 10.1186/1471-2105-8-69
77. Kuhn D. E., Martin M. M., Feldman D. S., Terry A. V. Jr., Nuovo G. J., Elton T. S., Experimental validation of miRNA targets. Methods 2008 44 1 47 54 2-s2.0-37349042903 10.1016/j.ymeth.2007.09.005 (Pubitemid 350297983)
78. Martin M. M., Lee E. J., Buckenberger J. A., Schmittgen T. D., Elton T. S., MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblast. The Journal of Biological Chemistry 2006 281 27 18277 18284 2-s2.0-33745826614 10.1074/jbc.M601496200 (Pubitemid 44035484)
79. Martin M. M., Buckenberger J. A., Jiang J., Malana G. E., Nuovo G. J., Chotani M., Feldman D. S., Schmittgen T. D., Elton T. S., The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding. The Journal of Biological Chemistry 2007 282 33 24262 24269 2-s2.0-34548207751 10.1074/jbc.M701050200 (Pubitemid 47328062)
80. Sansom S. E., Nuovo G. J., Martin M. M., MiR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. American Journal of Physiology Gastrointestinal and Liver Physiology. In press
81. Kuhn D. E., Nuovo G. J., Martin M. M., Malana G. E., Pleister A. P., Jiang J., Schmittgen T. D., Terry A. V. Jr., Gardiner K., Head E., Feldman D. S., Elton T. S., Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochemical and Biophysical Research Communications 2008 370 3 473 477 2-s2.0-42749095242 10.1016/j.bbrc.2008.03.120
82. Kuhn D. E., Nuovo G. J., Terry A. V. Jr., Martin M. M., Malana G. E., Sansom S. E., Pleister A. P., Beck W. D., Head E., Feldman D. S., Elton T. S., terry.elton@osumc.edu Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human down syndrome brains. The Journal of Biological Chemistry 2010 285 2 1529 1543 2-s2.0-74049088856 10.1074/jbc.M109.033407
83. Sethupathy P., Borel C., Gagnebin M., Grant G. R., Deutsch S., Elton T. S., Hatzigeorgiou A. G., Antonarakis S. E., Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3′ untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. American Journal of Human Genetics 2007 81 2 405 413 2-s2.0-34547727263 10.1086/519979 (Pubitemid 47236088)
84. Murdoch J. C., Rodger J. C., Rao S. S., Down's syndrome: an atheroma free model? British Medical Journal 1977 2 6081 226 228 2-s2.0-0017371432 (Pubitemid 8144869)
85. Yla-Herttuala S., Luoma J., Nikkari T., Kivimaki T., Down's syndrome and atherosclerosis. Atherosclerosis 1989 76 2-3 269 272 2-s2.0-0024603801 (Pubitemid 19101046)
86. Kapell D., Nightingale B., Rodriguez A., Lee J. H., Zigman W. B., Schupf N., Prevalence of chronic medical conditions in adults with mental retardation: comparison with the general population. Mental Retardation 1998 36 4 269 279 2-s2.0-0031851735 10.1352/0047-6765(1998)0360269:POCMCI>2.0.CO;2 (Pubitemid 28377642)
87. Draheim C. C., McCubbin J. A., Williams D. P., Differences in cardiovascular disease risk between nondiabetic adults with mental retardation with and without Down syndrome. American Journal on Mental Retardation 2002 107 3 201 234 2-s2.0-18344366338
88. Greene A. K., Kim S., Rogers G. F., Fishman S. J., Olsen B. R., Mulliken J. B., Risk of vascular anomalies with Down syndrome. Pediatrics 2008 121 1 e135 e140 2-s2.0-38049048634 10.1542/peds.2007-1316
89. Baird P. A., Sadovnick A. D., Causes of death to age 30 in Down syndrome. American Journal of Human Genetics 1988 43 3 239 248 2-s2.0-0023712265
90. Brattstrom L., Englund E., Brun A., Does Down syndrome support homocysteine theory of arteriosclerosis? The Lancet 1987 1 8529 391 392 2-s2.0-0023107659 (Pubitemid 17010060)
91. Pueschel S. M., Craig W. Y., Haddow J. E., Lipids and lipoproteins in persons with Down's syndrome. Journal of Intellectual Disability Research 1992 36 4 365 369 2-s2.0-0026806423
92. Licastro F., Marocchi A., Penco S., Porcellini E., Lio D., Dogliotti G., Corsi M. M., Does Down's syndrome support the homocysteine theory of atherogenesis?. Experience in elderly subjects with trisomy 21. Archives of Gerontology and Geriatrics 2006 43 3 381 387 2-s2.0-33750338304 10.1016/j.archger.2006.01.003 (Pubitemid 44634131)
93. Goi G., Baquero-Herrera C., Licastro F., Dogliotti G., Corsi M. M., Advanced oxidation protein products (AOPP) and high-sensitive C-reactive protein (hs-CRP) in an atheroma-free model: Down's syndrome. International Journal of Cardiology 2006 113 3 427 429 2-s2.0-33750695725 10.1016/j.ijcard.2005.10.019 (Pubitemid 44708322)
94. Boettger T., Beetz N., Kostin S., Schneider J., Krüger M., Hein L., Braun T., Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. Journal of Clinical Investigation 2009 119 9 2634 2647 2-s2.0-70349213385 10.1172/JCI38864
95. Cordes K. R., Sheehy N. T., White M. P., Berry E. C., Morton S. U., Muth A. N., Lee T.-H., Miano J. M., Ivey K. N., Srivastava D., MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009 460 7256 705 710 2-s2.0-68449097267 10.1038/nature08195
96. Daugherty A., Manning M. W., Cassis L. A., Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. Journal of Clinical Investigation 2000 105 11 1605 1612 2-s2.0-0034129997 (Pubitemid 30390311)
97. Bao L., Zhou M., Wu L., Lu L., Goldowitz D., Williams R. W., Cui Y., PolymiRTS Database: linking polymorphisms in microRNA target sites with complex traits. Nucleic Acids Research 2007 35 1 D51 D54 2-s2.0-33846118697 10.1093/nar/gkl797 (Pubitemid 46056169)
98. Hariharan M., Scaria V., Brahmachari S. K., dbSMR: a novel resource of genome-wide SNPs affecting microRNA mediated regulation. BMC Bioinformatics 2009 10, article 108 2-s2.0-65649124187 10.1186/1471-2105-10-108
99. Hiard S., Charlier C., Coppieters W., Georges M., Baurain D., Patrocles: a database of polymorphic miRNA-mediated gene regulation in vertebrates. Nucleic Acids Research 2009 38 supplement 1 D640 D651 2-s2.0-34249880779 10.1093/nar/gkp926
100. Abelson J. F., Kwan K. Y., O'Roak B. J., Baek D. Y., Stillman A. A., Morgan T. M., Mathews C. A., Pauls D. L., Rašin M.-R., Gunel M., Davis N. R., Ercan-Sencicek A. G., Guez D. H., Spertus J. A., Leckman J. F., Dure L. S. IV, Kurlan R., Singer H. S., Gilbert D. L., Farhi A., Louvi A., Lifton R. P., Šestan N., State M. W., Medicine: sequence variants in SLITRK1 are associated with Tourette's syndrome. Science 2005 310 5746 317 320 2-s2.0-26844498125 10.1126/science.1116502 (Pubitemid 41457198)
101. He H., Jazdzewski K., Li W., Liyanarachchi S., Nagy R., Volinia S., Calin G. A., Liu C.-G., Franssila K., Suster S., Kloos R. T., Croce C. M., de La Chapelle A., The role of microRNA genes in papillary thyroid carcinoma. Proceedings of the National Academy of Sciences of the United States of America 2005 102 52 19075 19080 2-s2.0-30044436911 10.1073/pnas.0509603102 (Pubitemid 43049568)
102. Clop A., Marcq F., Takeda H., Pirottin D., Tordoir X., Bibé B., Bouix J., Caiment F., Elsen J.-M., Eychenne F., Larzul C., Laville E., Meish F., Milenkovic D., Tobin J., Charlier C., Georges M., A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nature Genetics 2006 38 7 813 818 2-s2.0-33745577150 10.1038/ng1810 (Pubitemid 43980603)
103. Züchner S., Wang G., Tran-Viet K.-N., Nance M. A., Gaskell P. C., Vance J. M., Ashley-Koch A. E., Pericak-Vance M. A., Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. American Journal of Human Genetics 2006 79 2 365 369 2-s2.0-33746554263 10.1086/505361 (Pubitemid 44141835)
104. Mishra P. J., Humeniuk R., Mishra P. J., Longo-Sorbello G. S. A., Banerjee D., Bertino J. R., A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proceedings of the National Academy of Sciences of the United States of America 2007 104 33 13513 13518 2-s2.0-34548059198 10.1073/pnas.0706217104 (Pubitemid 47293976)
105. Adams B. D., Furneaux H., White B. A., The micro-ribonucleic acid (miRNA) miR-206 targets the human estrogen receptor- α (ER α) and represses ER α messenger RNA and protein expression in breast cancer cell lines. Molecular Endocrinology 2007 21 5 1132 1147 2-s2.0-34250843675 10.1210/me.2007-0022 (Pubitemid 46984764)
106. Nicoloso M. S., Sun H., Spizzo R., Kim H., Wickramasinghe P., Shimizu M., Wojcik S. E., Ferdin J., Kunej T., Xiao L., Manoukian S., Secreto G., Ravagnani F., Wang X., Radice P., Croce C. M., Davuluri R. V., rdavuluri@wistar.org Calin G. A., gcalin@mdanderson.org Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Research 2010 70 7 2789 2798 2-s2.0-0347626097 10.1158/0008-5472.CAN-09-3541
107. Baudin B., Polymorphism in angiotensin II receptor genes and hypertension. Experimental Physiology 2005 90 3 277 282 2-s2.0-18844390034 10.1113/expphysiol.2004.028456 (Pubitemid 40685839)
108. Bonnardeaux A., Davies E., Jeunemaitre X., Féry I., Charru A., Clauser E., Tiret L., Cambien F., Corvol P., Soubrier F., Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension 1994 24 1 63 69 2-s2.0-0028290165 (Pubitemid 24195405)
109. Kainulainen K., Perola M., Terwilliger J., Kaprio J., Koskenvuo M., Syvänen A.-C., Vartiainen E., Peltonen L., Kontula K., Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999 33 3 844 849 2-s2.0-0033037576 (Pubitemid 29140444)
110. Wang W. Y. S., Zee R. Y. L., Morris B. J., Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Clinical Genetics 1997 51 1 31 34 2-s2.0-0031044981 (Pubitemid 27116896)
111. Kobashi G., Hata A., Ohta K., Yamada H., Kato E. H., Minakami H., Fujimoto S., Kondo K., A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. Journal of Human Genetics 2004 49 4 182 186 2-s2.0-2442658204 10.1007/s10038-004-0129-4 (Pubitemid 38657566)
112. Wang J.-G., Staessen J. A., Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease. European Journal of Pharmacology 2000 410 2-3 289 302 2-s2.0-0034723039 10.1016/S0014-2999(00)00822-0 (Pubitemid 32008151)
113. Jiang Z., Zhao W., Yu F., Xu G., Association of angiotensin II type 1 receptor gene polymorphism with essential hypertension. Chinese Medical Journal 2001 114 12 1249 1251 2-s2.0-0035677578 (Pubitemid 34041492)
114. Ono K., Mannami T., Baba S., Yasui N., Ogihara T., Iwai N., Lack of association between angiotensin II type 1 receptor gene polymorphism and hypertension in Japanese. Hypertension Research 2003 26 2 131 134 2-s2.0-0033811353 10.1291/hypres.26.131 (Pubitemid 36372331)
115. Palatini P., Ceolotto G., Dorigatti F., Mos L., Santonastaso M., Bratti P., Papparella I., Pessina A. C., Semplicini A., Angiotensin II type 1 receptor gene polymorphism predicts development of hypertension and metabolic syndrome. American Journal of Hypertension 2009 22 2 208 214 2-s2.0-58549085966 10.1038/ajh.2008.319
116. Osterop A. P. R. M., Kofflard M. J. M., Sandkuijl L. A., Ten Cate F. J., Krams R., Schalekamp M. A. D. H., Danser A. H. J., AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998 32 5 825 830 2-s2.0-0031597427 (Pubitemid 28530214)
117. Makeeva O. A., Puzyrev K. V., Pavlukova E. N., Koshelskaya O. A., Golubenko M. V., Efimova E. V., Kucher A. N., Tsymbaliuk I. V., Karpov R. S., Puzyrev V. P., ACE and AGTR1 genes polymorphisms in left ventricular hypertrophy pathogenesis in humans. Molekulyarnaya Biologiya 2004 38 6 990 996 2-s2.0-0031597427 (Pubitemid 44558336)
118. Smilde T. D. J., Zuurman M. W., Hillege H. L., van Veldhuisen D. J., van Gilst W. H., van der Steege G., Voors A. A., Kors J. A., de Jong P. E., Navis G., Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy. American Journal of Hypertension 2007 20 10 1097 1103 2-s2.0-34548831966 10.1016/j.amjhyper.2007.04. 023 (Pubitemid 47446171)
119. Lajemi M., Labat C., Gautier S., Lacolley P., Safar M., Asmar R., Cambien F., Benetos A., Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects. Journal of Hypertension 2001 19 3 407 413 2-s2.0-0035120417 10.1097/00004872-200103000-00008 (Pubitemid 32195376)
120. Díez J., Laviades C., Orbe J., Zalba G., López B., González A., Mayor G., Páramo J. A., Beloqui O., The A1166C polymorphism of the AT1 receptor gene is associated with collagen type I synthesis and myocardial stiffness in hypertensives. Journal of Hypertension 2003 21 11 2085 2092 2-s2.0-1542270216 10.1097/00004872-200311000-00018 (Pubitemid 38296870)
121. Benetos A., Gautier S., Ricard S., Topouchian J., Asmar R., Poirier O., Larosa E., Guize L., Safar M., Soubrier F., Cambien F., Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996 94 4 698 703 2-s2.0-9544250399 (Pubitemid 26289224)
122. Tiret L., Blanc H., Ruidavets J.-B., Arveiler D., Luc G., Jeunemaitre X., Tichet J., Mallet C., Poirier O., Plouin P.-F., Cambien F., Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. Journal of Hypertension 1998 16 1 37 44 2-s2.0-6844260524 10.1097/00004872-199816010-00007 (Pubitemid 28069818)
123. Wu C.-K., Tsai C.-T., Hwang J.-J., Luo J.-L., Juang J. J.-M., Hsu K.-L., Lai L.-P., Lin J.-L., Tseng C.-D., Chiang F.-T., Renin-angiotensin system gene polymorphisms and diastolic heart failure. European Journal of Clinical Investigation 2008 38 11 789 797 2-s2.0-54349122544 10.1111/j.1365-2362.2008. 02017.x
124. Lin J., Hu F. B., Qi L., Curhan G. C., Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus. BMC Nephrology 2009 10 1, article 9 2-s2.0-64649104042 10.1186/1471-2369-10-9
125. Amir O., Amir R. E., Paz H., Attias E., Sagiv M., Lewis B. S., lewis@tx.technion.ac.il Relation between AT1R gene polymorphism and long-term outcome in patients with heart failure. Cardiology 2009 112 2 151 157 2-s2.0-0033501322 10.1159/000143390
126. Jones G. T., Thompson A. R., van Bockxmeer F. M., Hafez H., Cooper J. A., Golledge J., Humphries S. E., Norman P. E., Van Rij A. M., Angiotensin II type 1 receptor 1166C polymorphism is associated with abdominal aortic aneurysm in three independent cohorts. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 4 764 770 2-s2.0-42249103284 10.1161/ATVBAHA.107.155564 (Pubitemid 351651328)
127. McColgan P., Peck G. E., Greenhalgh R. M., Sharma P., The genetics of abdominal aortic aneurysms: a comprehensive meta-analysis involving eight candidate genes in over 16,700 patients. International Surgery 2009 94 4 350 358 2-s2.0-0041886570
128. Cameron V. A., Mocatta T. J., Pilbrow A. P., Frampton C. M., Troughton R. W., Richards A. M., Winterbourn C. C., Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure. Hypertension 2006 47 6 1155 1161 2-s2.0-33744988762 10.1161/01.HYP.0000222893. 85662.cd (Pubitemid 44289173)
129. Spielman R. S., Bastone L. A., Burdick J. T., Morley M., Ewens W. J., Cheung V. G., Common genetic variants account for differences in gene expression among ethnic groups. Nature Genetics 2007 39 2 226 231 2-s2.0-33846631884 10.1038/ng1955 (Pubitemid 46184354)